New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 20, 2014
06:26 EDTAWAYHomeAway price target raised to $53 from $43 at Piper Jaffray
Piper Jaffray raised its price target for HomeAway shares to $53 citing the company's strong Q4 results and reiterates an Overweight rating on the stock. Piper attributes the company's lower than expected earnings and EBITDA in Q4 to one-time expenses related to the Stayz acquisition and notes overall listings growth accelerated to 25% year-over-year.
News For AWAY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 24, 2015
12:49 EDTAWAYOn The Fly: Top stock stories at midday
Subscribe for More Information
09:20 EDTAWAYOn The Fly: Pre-market Movers
UP AFTER EARNINGS: eHealth (EHTH), up 24.7%... Starbucks (SBUX), up 4.2%... Microsoft (MSFT), up 5.2%... Google (GOOG, GOOGL), up 3.2% and up 3.7%, respectively... Amazon (AMZN), up 12% after reporting quarterly results and announcing shopping app for Apple Watch... Gigamon (GIMO), up 16.5%... Juniper Networks (JNPR), up 6.6%. ALSO HIGHER: Molycorp (MCP), up 10.2% following a Bloomberg report that China's export tax decision may boost rare earth demand... Mattel (MAT), up 4.4% after being upgraded to Buy from Neutral at Goldman... Innocoll (INNL), up 13.1% after 3.3M share Secondary priced at $9.00... Cytosorbents (CTSO), up 9.7% after CEO comments on CytoSorb in letter to shareholders. DOWN AFTER EARNINGS: Biogen (BIIB), down 4.7%... Altera (ALTR), down 1.7%... Pandora (P), down 4%... ResMed (RMD), down 8.7%... Xerox (XRX), down 4.7%... HomeAway (AWAY), down 3.6% after reporting quarterly results and departure of officers. ALSO LOWER: Ubiquiti (UBNT), down 14.4% following CFO resignation and preliminary third quarter results... 3D Systems (DDD), down 10.4% after reporting preliminary first quarter results... StemCells (STEM), down 23.2% after filing to sell common stock... Aerie Pharmaceuticals (AERI), down 54.7% after Rhopressa Phase 3 trial did not meet primary endpoint.
09:14 EDTAWAYHomeAway downgraded to Outperform from Strong Buy at Raymond James
Raymond James downgraded HomeAway to Outperform and lowered its price target to $35 from $40 following lowered 2015 revenue and EBITDA guidance, a slower pay-per-booking revenue ramp, and the retirement of co-founder Carl Shephard and resignation of COO Brent Bellm. The firm remains positive on HomeAway long-term and views the company as an attractive takeover target.
April 23, 2015
19:16 EDTAWAYOn The Fly: After Hours Movers
Subscribe for More Information
17:57 EDTAWAYHomeAway COO Bellm, CSO Shepherd to resign, Hale appointed COO
Subscribe for More Information
16:18 EDTAWAYHomeAway sees FY15 revenue $493M-$500M, consensus $513.24M
Subscribe for More Information
16:17 EDTAWAYHomeAway sees Q2 revenue $122M-$124M, consensus $129.62M
Subscribe for More Information
16:16 EDTAWAYHomeAway reports Q1 EPS 11c, consensus 13c
Subscribe for More Information
15:00 EDTAWAYNotable companies reporting after market close
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use